The selected dose in the pivotal phase is lower than for other drug candidates in clinical trials or gene therapy drugs for Duchenne.

Vyana Care offers personalized, evidence-based physiotherapy and digital rehabilitation, helping patients like Reema Sinha avoid surgery through movement-focused, root-cause treatments.

Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophyBLA supported by positive pivotal HOPE-3 Phase 3 results, ...